Avalo Therapeutics Inc将于2026年4月26日起五个工作日内向证券持有人代表支付225万美元——美国证券交易委员会文件

美股速递
Apr 28

根据最新提交至美国证券交易委员会的文件披露,生物制药公司Avalo Therapeutics Inc已明确支付时间表,其需在2026年4月26日之后的五个工作日内,向证券持有人代表支付总额达225万美元的款项。

该笔资金的支付时限与具体金额在监管文件中被重点标注,体现出公司对股东权益保障的合规承诺。作为专注于炎症性疾病与免疫学领域创新疗法开发的临床阶段企业,此次支付安排或与其近期资本运作及股东协议条款的履行密切相关。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10